Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02838901Phase 2Completed
Phase 2, randomised, double-blind trial in ischemic stroke (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoints: Adherence With Intervention at 30 days, Number of Participants With Adverse Treatment-altering Events at 30 days and 2 more. Started Jun 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02838901.